School-based Group Acceptance and Commitment Therapy for Adolescents

April 14, 2026 updated by: Jennifer Yee Man Tang, Chinese University of Hong Kong

Thriving Through the Storms: A School-based Mental Health Promotion Program for Building Psychological Flexibility and Resilience

The objective of the investigators' mental health promotion intervention premised on the Acceptance and Commitment Therapy (ACT) framework in secondary school settings aims to enhance young people's psychological flexibility and reduce their emotional distress. ACT is an evidence-based approach that encourages individuals to act in alignment with their identified values. The investigator's team will employ an ACT protocol for adolescents developed by Louise Hayes and Joseph Ciarrochi. The study includes a single-group study design. The investigator will compare the pre- and post-intervention data to assess the feasibility and potential effectiveness of the group intervention.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

61

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Shatin, Hong Kong
        • Department of Educational Psychology, The Chinese University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Eligible participants are adolescents who reported mild to moderate severity of psychological distress, including those who report:

  • a score of 5-19 on the Patient Health Questionnaire (PHQ-9), or
  • a score of 5-14 on the General Anxiety Disorder-7, or
  • a score ≥14 on the Perceived Stress Scale.

Exclusion Criteria:

Adolescents will be excluded if they exhibit or report:

  • violent or aggressive behavior, or
  • active self-injurious or suicidal thought, or
  • active psychotic symptom.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Four sessions of group acceptance and commitment therapy, with each session lasting for 1.5 hours.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Acceptance and Action Questionnaire - II
Time Frame: Baseline and 4 weeks
Baseline and 4 weeks
The 14-item Resilience Scale
Time Frame: Baseline and 4 weeks
Baseline and 4 weeks
Patient Health Questionnaire - 9
Time Frame: Baseline and 4 weeks
Baseline and 4 weeks
General Anxiety Disorder - 7
Time Frame: Baseline and 4 weeks
Baseline and 4 weeks
Perceived Stress Scale
Time Frame: Baseline and 4 weeks
Baseline and 4 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Satisfaction with Life Scale
Time Frame: Baseline and 4 weeks
Baseline and 4 weeks
Pittsburgh Sleep Quality Index
Time Frame: Baseline and 4 weeks
Baseline and 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2023

Primary Completion (Actual)

June 30, 2024

Study Completion (Actual)

August 31, 2024

Study Registration Dates

First Submitted

September 9, 2023

First Submitted That Met QC Criteria

September 9, 2023

First Posted (Actual)

September 15, 2023

Study Record Updates

Last Update Posted (Actual)

April 17, 2026

Last Update Submitted That Met QC Criteria

April 14, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Acceptance and commitment therapy

Subscribe